http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2140307-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0ff24a29953a79f489801b1d0ef2627 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0235d0f90b95197f1669aed92a8ed0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a2adcb55a63997a9149d1705a1a5553 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00 |
| filingDate | 1999-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70b061a0801c3cb128cab86e2d97241e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d151fffbe3b8c9a50c8c594bf5a247c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1ea0b36c06fc52145dd089d19ee3ca8 |
| publicationDate | 1999-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2140307-C1 |
| titleOfInvention | Method of treating chronic urethroprostatitis with chlamys and urea- mycoplasma etiology |
| abstract | FIELD: urology. SUBSTANCE: treatment is started by intramuscular injection of immunostimulator (neovir) once a day with 48 hr pause, total number of injections being 5-10. Consecutive administration of antibiotics and physiotherapeutic procedures is started on the second neovir injection day. Two antibacterial preparations are administered chosen from different groups taking into account sensitivity of infecting agent, administration being carried out for 14-28 days without pauses. Physiotherapeutic procedures consist in daily vibramycinum ultraphonophoresis carried out transrectally in 4-10 ms pulse mode with intensity 0.2-0.4 W/sq.cm, 5-7 min duration, and total number of procedures 10-12. EFFECT: enhanced treatment efficiency due to more selective action on infecting agent. 4 cl, 3 tbl, 3 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2534853-C1 |
| priorityDate | 1999-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.